NS.MEDIC: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
NS.MEDIC
Largest movements
- Current investments -€80,000
down €80,000 (-100.0%), from €80,000 to €0
- Cash +€70,885
up €70,885 (+41.3%), from €171,455 to €242,340
mainly Net result for the year (+€120,995) and Current investments (+€80,000)
- Tangible fixed assets +€35,477
up €35,477 (+298.7%), from €11,876 to €47,352
of which Other tangible fixed assets: +€38,914
- Deferred charges and accrued income +€3,533
up €3,533 (+14.0%), from €25,242 to €28,775
- Receivables within one year +€3,293
up €3,293 (+109.8%), from €2,999 to €6,292
of which Trade receivables: +€2,000
- Profit (loss) carried forward -€82,500
down €82,500 (-29.2%), from €282,737 to €200,237
- Other debts +€50,000
new in 2025: €50,000
- Reserves +€25,000
new in 2025: €25,000
- Debts after one year +€20,738
new in 2025: €20,738
- Tax, wage and social debts +€10,407
up €10,407 (+159.1%), from €6,542 to €16,949
- Gross operating margin -€81,312
down €81,312 (-32.0%), from €254,356 to €173,044
- Taxes -€19,566
down €19,566 (-31.8%), from €61,542 to €41,976
- Depreciation +€4,310
up €4,310 (+61.6%), from €6,996 to €11,307
- Financial income +€3,040
new in 2025: €3,040
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €291,572 | €325,240 | +€33,668 | +11.5% |
| Fixed assets | 21/28 | €11,876 | €47,833 | +€35,957 | +302.8% |
| Intangible fixed assets | 21 | - | €480 | +€480 | |
| Tangible fixed assets | 22/27 | €11,876 | €47,352 | +€35,477 | +298.7% |
| Furniture and vehicles | 24 | €11,876 | €8,439 | -€3,437 | -28.9% |
| Other tangible fixed assets | 26 | - | €38,914 | +€38,914 | |
| Current assets | 29/58 | €279,696 | €277,407 | -€2,288 | -0.8% |
| Amounts receivable within one year | 40/41 | €2,999 | €6,292 | +€3,293 | +109.8% |
| Trade receivables | 40 | - | €2,000 | +€2,000 | |
| Other amounts receivable | 41 | €2,999 | €4,292 | +€1,293 | +43.1% |
| Current investments | 50/53 | €80,000 | €0 | -€80,000 | -100.0% |
| Cash at bank and in hand | 54/58 | €171,455 | €242,340 | +€70,885 | +41.3% |
| Deferred charges and accrued income | 490/1 | €25,242 | €28,775 | +€3,533 | +14.0% |
| Total equity and liabilities | 10/49 | €291,572 | €325,240 | +€33,668 | +11.5% |
| Equity | 10/15 | €284,737 | €227,237 | -€57,500 | -20.2% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Reserves | 13 | - | €25,000 | +€25,000 | |
| Distributable reserves | 133 | - | €25,000 | +€25,000 | |
| Profit (loss) carried forward | 14 | €282,737 | €200,237 | -€82,500 | -29.2% |
| Amounts payable | 17/49 | €6,835 | €98,003 | +€91,168 | +1333.9% |
| Amounts payable after more than one year | 17 | - | €20,738 | +€20,738 | |
| Financial debts | 170/4 | - | €20,738 | +€20,738 | |
| Amounts payable within one year | 42/48 | €6,835 | €77,265 | +€70,431 | +1030.5% |
| Current portion of amounts payable after more than one year | 42 | - | €5,642 | +€5,642 | |
| Trade debts | 44 | €293 | €4,675 | +€4,382 | +1496.2% |
| Suppliers | 440/4 | €293 | €4,675 | +€4,382 | +1496.2% |
| Taxes, remuneration and social security | 45 | €6,542 | €16,949 | +€10,407 | +159.1% |
| Taxes | 450/3 | €6,542 | €16,949 | +€10,407 | +159.1% |
| Other amounts payable | 47/48 | - | €50,000 | +€50,000 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €6,996 | €11,307 | +€4,310 | +61.6% |
| Other operating charges | 640/8 | €1,692 | €720 | -€972 | -57.4% |
| Gross operating margin | 9900 | €254,356 | €173,044 | -€81,312 | -32.0% |
| Operating profit (loss) | 9901 | €245,667 | €161,017 | -€84,650 | -34.5% |
| Financial income | 75/76B | - | €3,040 | +€3,040 | |
| Recurring financial income | 75 | - | €3,040 | +€3,040 | |
| Financial charges | 65/66B | €86 | €1,086 | +€1,000 | +1163.3% |
| Recurring financial charges | 65 | €86 | €1,086 | +€1,000 | +1163.3% |
| Profit (loss) for the period before taxes | 9903 | €245,581 | €162,971 | -€82,611 | -33.6% |
| Income taxes | 67/77 | €61,542 | €41,976 | -€19,566 | -31.8% |
| Profit (loss) for the period | 9904 | €184,040 | €120,995 | -€63,045 | -34.3% |
| Profit (loss) for the period to be appropriated | 9905 | €184,040 | €120,995 | -€63,045 | -34.3% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.